Logo
GBR logo in regulatory updates.
Thumbnail image
Custom digital health interventions for patients

AI in Life Sciences – Covid pushes AI driven clinical trials and drug manufacturing into the limelight

ICON’s CIO, Tom Leary discusses the challenges to patient recruitment during the COVID pandemic and how big data, combined with advanced AI algorithms processing has the potential to reduce trial costs.